Treatment of vascular abnormalities using nanoparticles
OwnerDanyang Cheninventor
Life of this patent
Estimating the term…
Abstract
Vascular abnormalities in a patient are treated by administering a therapeutically effective amount of an agent that reduces angiogenesis. The agent comprises an vascular leakage angiogenic inhibitor and/or vascular leakage angiogenic inhibitor expression plasmid/vector encapsulated by a biocompatible nanoparticle.
Claims21
A method of treating vascular abnormalities in a patient, said method comprising administering to the patient a therapeutically effective amount of an agent that reduces angiogenesis, said agent further comprising biocompatible nanoparticles containing at least one of an vascular leakage angiogenic inhibitor and vascular leakage angiogenic inhibitor expression plasmid/vector.
A method of preparing an agent for treatment of vascular abnormalities, said method comprising encapsulating at least one of an vascular leakage angiogenic inhibitor and vascular leakage angiogenic inhibitor expression plasmid/vector in biocompatible nanoparticles.
An agent for treatment of vascular abnormalities comprising biocompatible nanoparticles containing at least one of an vascular leakage angiogenic inhibitor and vascular leakage angiogenic inhibitor expression plasmid/vector.
Dependencies are inferred from the claim text.